Key result
Hemodialysis without anticoagulants was well tolerated and safe in 6 uremic patients with high bleeding risk, with no devices lost to clotting or rupture across 20 sessions.
Why the study?
Is hemodialysis without anticoagulants safe and feasible in uremic patients with high bleeding risk?
Observational (n=6)
Is hemodialysis without anticoagulants safe and feasible in uremic patients with high bleeding risk?
Hemodialysis without heparin is feasible and safe in critically ill uremic patients with a high bleeding risk.
Answers are grounded in this paper and cite their sources.
Supports feasibility of anticoagulant-free hemodialysis in high-bleeding-risk uremia; leaves open confirmation in larger prospective trials before practice change.
Twenty hemodialysis were performed in six uremic patients with high bleeding risk, with a technique avoiding any anticoagulant drug before or during the treatment. The treatment was well tolerated in all patients and no alterations were observed in the intrinsic clotting system evaluated before, during and after hemodialysis. During the study, devices were never lost because of clotting or rupture, and their performances were similar to those obtained on heparin hemodialysis. We suggest that in critically ill patients, needing dialysis, hemodialysis without heparin is possible and safe.
No takes yet. Share an insight, caveat, or question.
Casati et al. (1982) conducted an observational in Uremia with high bleeding risk (n=6). Hemodialysis without anticoagulants vs. Heparin hemodialysis was evaluated on Tolerability, intrinsic clotting system alterations, and device loss. Hemodialysis without anticoagulants was well tolerated and safe in 6 uremic patients with high bleeding risk, with no devices lost to clotting or rupture across 20 sessions.
Synapse has enriched 10 related papers. Consider them for comparative context: